Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Geron (Nasdaq: GERN) announced participation in the Goldman Sachs 47th Annual Global Healthcare Conference.

Rhea-AI Summary

Geron (Nasdaq: GERN) announced participation in the Goldman Sachs 47th Annual Global Healthcare Conference. Company management will join a fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET in Miami, Florida.

A live and archived audio webcast will be available via the Investors & Media section of Geron’s website.

Argus Jun 1 session

-3.20% close to close Open Argus

Details

News Market Reaction – GERN

On Jun 1, the day this news came out, GERN closed 3.20% below the previous close.

Data tracked by StockTitan Argus for the Jun 1 session.

Market Context

This announcement highlights Geron’s ongoing engagement with investors through a scheduled fireside ...

Analysis

This announcement highlights Geron’s ongoing engagement with investors through a scheduled fireside chat at the Goldman Sachs healthcare conference on June 8, 2026 at 8:40 a.m. ET. It follows recent updates on RYTELO® commercialization, Q1 2026 results with $51.8M in product revenue, and presentation plans at major medical meetings. Investors may watch for any incremental commentary on revenue trends, expense discipline, and progress of late-stage trials during the webcast.

Key Figures

Conference edition: 47th Annual Conference date: June 8, 2026 Start time: 8:40 a.m. ET

Conference edition

47th Annual

Goldman Sachs Global Healthcare Conference

Conference date

June 8, 2026

Scheduled fireside chat

Start time

8:40 a.m. ET

Fireside chat schedule

Historical Context

5 past events · Latest: May 18

5 events

1. May 18

   Employee equity grants

   24h Move

   -0.8%

   Inducement stock options for five new employees under Nasdaq Rule 5635(c)(4).

2. May 12

   Clinical data update

   24h Move

   +0.7%

   Positive real-world RYTELO data in LR-MDS and planned EHA/ASCO presentations.

3. May 06

   Q1 2026 earnings

   24h Move

   -4.2%

   Strong RYTELO revenue, narrowed loss, reiterated 2026 guidance and progress updates.

4. May 05

   Investor conferences

   24h Move

   +5.1%

   Planned presentations at Bank of America and Stifel oncology investor events.

5. Apr 22

   Earnings date notice

   24h Move

   +3.3%

   Announcement of Q1 2026 results date and related conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that members of the management team are scheduled to participate in a fireside chat at the Goldman Sachs 47^th Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:40 a.m. ET in Miami, FL.

A live and archived audio webcast of the fireside chat will be available through the Investors & Media section of Geron’s website at www.geron.com.

About Geron
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO^® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

Investors and Media
Dawn Schottlandt
Senior Vice President, Investor Relations and Corporate Affairs
dschottlandt@geron.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Geron (GERN) present at the Goldman Sachs 47th Annual Global Healthcare Conference?

Geron will participate in a fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET. According to Geron, the session will take place during the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, Florida.

What type of session will Geron (GERN) hold at the Goldman Sachs 2026 healthcare conference?

Geron management is scheduled for a fireside chat at the conference. According to Geron, company leaders will speak at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, offering investors an opportunity to hear management’s latest perspectives.

How can investors listen to Geron’s (GERN) Goldman Sachs healthcare conference presentation?

Investors can access a live and archived audio webcast of Geron’s fireside chat online. According to Geron, the webcast will be available through the Investors & Media section of the company’s website at www.geron.com.

Will a replay of Geron’s (GERN) June 8, 2026 conference fireside chat be available?

Yes, an archived audio webcast of the fireside chat will be available after the event. According to Geron, both live and archived access will be provided via the Investors & Media section of its corporate website.

Where is the Goldman Sachs 47th Annual Global Healthcare Conference with Geron (GERN) being held?

The conference featuring Geron’s fireside chat will take place in Miami, Florida. According to Geron, the company’s management team will speak on June 8, 2026, at 8:40 a.m. ET during this event.